calendar
25,484 catalysts · 16,885 approval · 3,555 device 510k · 2,327 grant · 1,041 device pma · 926 device recall · 750 recall
next 91 dayslessmore
MonWedFri
25,484 catalysts · 16,885 approval · 3,555 device 510k · 2,327 grant · 1,041 device pma · 926 device recall · 750 recall
Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: TORRENT. Form: CAPSULE. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS
Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL
Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: HISAMITSU PHARM CO. Form: PATCH. Route: TOPICAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: DANCO LABS LLC. Form: TABLET. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: PH HEALTH. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: DR REDDYS LABS SA. Form: TABLET. Route: ORAL-28
Sponsor: ZYLA. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AM REGENT. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS UT INC. Form: CAPSULE. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SOLUTION. Route: ORAL
Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: PAI HOLDINGS. Form: SOLUTION. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SOLUTION. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL
Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL